Essential cross-linking role for FcgRIIB in the in vivo activity of anti-CD40 monoclonal antibody

被引：0
|
作者：
White, A. L. [1 ]
Chan, H. T. C. [1 ]
French, R. R. [1 ]
Roghanian, A. [1 ]
Mockridge, C. I. [1 ]
Tutt, A. L. [1 ]
Verbeek, J. S. [2 ]
Noelle, R. J. [3 ]
Al-Shamkhani, A. [1 ]
Cragg, M. S. [1 ]
Beers, S. A. [1 ]
Glennie, M. J. [1 ]
机构：
[1] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Kings Coll London, MRC, Ctr Transplantat, London WC2R 2LS, England
来源：
IMMUNOLOGY | 2011年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [41] Phase I trial of a humanized anti-CD40 monoclonal antibody (SGN-40) in the treatment of multiple myeloma.
    Hussein, MA
    Berenson, JR
    Niesvizky, R
    Munshi, NC
    Anderson, KC
    Ryan, KL
    Baumgartner, KT
    Miller, DM
    Drachman, JG
    McDonald, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 580S - 580S
  • [42] In vitro testing of an anti-CD40 monoclonal antibody, clone 2C10, in primates and pigs
    Lee, Whayoung
    Satyananda, Vikas
    Iwase, Hayato
    Tanaka, Takayuki
    Miyagawa, Yuko
    Long, Cassandra
    Ayares, David
    Cooper, David K. C.
    Hara, Hidetaka
    TRANSPLANT IMMUNOLOGY, 2015, 33 (03) : 185 - 191
  • [43] Anti-CD40 ligand monoclonal antibody induces a permissive state, but not tolerance, for murine peripheral nerve allografts
    Brenner, MJ
    Tung, THH
    Mackinnon, SE
    Myckatyn, TM
    Hunter, DA
    Mohanakumar, T
    EXPERIMENTAL NEUROLOGY, 2004, 186 (01) : 59 - 69
  • [44] LOCAL CONVECTION-ENHANCED DELIVERY OF AN ANTI-CD40 AGONISTIC MONOCLONAL ANTIBODY INDUCES ANTITUMOR EFFECTS
    Shoji, Takuhiro
    Saito, Ryuta
    Chonan, Masashi
    Shibahara, Ichiyo
    Sato, Aya
    Kanamori, Masayuki
    Sonoda, Yukihiko
    Kondo, Tooru
    Ishii, Naoto
    Tominaga, Teiji
    NEURO-ONCOLOGY, 2016, 18 : 92 - 92
  • [45] Combined Anti-CD40 and Anti-IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
    von Scheidt, Bianca
    Leung, Patrick S. K.
    Yong, Michelle C. R.
    Zhang, Yu
    Towne, Jennifer E.
    Smyth, Mark J.
    Teng, Michele W. L.
    CANCER RESEARCH, 2014, 74 (09) : 2412 - 2421
  • [46] Effect and safety of anti-CD40 antibody on the survival of corneal xenotransplantation
    Kim, Jaeyoung
    Kim, Dong Hyun
    Choi, Hyuk Jin
    Lee, Hyun Ju
    Kim, Ji Hyun
    Kang, Hee Jung
    Park, Chung-Gyu
    Wee, Won Ryang
    Kim, Mee Kum
    XENOTRANSPLANTATION, 2015, 22 : S53 - S53
  • [47] In Vivo Characterization of Novel Non-Depleting Anti-CD40 Monoclonal Antibodies in Nonhuman Primates.
    Lowe, M.
    Thompson, P.
    Badel, I.
    Reimann, K.
    Strobert, E.
    Iwakoshi, N.
    Kirk, A.
    Larsen, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 474 - 474
  • [48] FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies
    Lang, Isabell
    Zaitseva, Olena
    Wajant, Harald
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [49] The in vivo antitumor activity of a humanized anti-CD26 monoclonal antibody
    Yeung, Pete
    Sun, Difei
    Banica, Monica
    Williams, Jason
    Cheung, Peter
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3548S - 3549S
  • [50] Differential activation of human platelets induced by Fc gamma receptor II cross-linking and by anti-CD9 monoclonal antibody
    Qi, RM
    Ozaki, Y
    Kuroda, K
    Asazuma, N
    Yatomi, Y
    Satoh, K
    Nomura, S
    Kume, S
    JOURNAL OF IMMUNOLOGY, 1996, 157 (12): : 5638 - 5645
12345